Carriazo S, Ortiz A, Fernandez-Fernandez B. First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists. Ann Intern Med 2023;176:eL230005.
PMID: 37068289